NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
24 January 2025
| Name: | BARD1 LIFE SCIENCES LIMITED (BD1) (This company subsequently changed its name to INOVIQ LTD. You should refer to that name for Status.) | |||||||||
| ISIN: | AU000000BD12 | |||||||||
| Date of Listing: | 18 April 1991 | |||||||||
| Subsequent Names: |
| |||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to INOVIQ LTD. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 009 070 384ABN: 58 009 070 384
Registration Date: 30 June 1983
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now INOVIQ LTD. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| INOVIQ LTD | 09/12/2021 | |
| BARD1 LIFE SCIENCES LIMITED | 14/06/2016 | 09/12/2021 |
| EUROGOLD LIMITED | 28/05/2002 | 14/06/2016 |
| ESMERALDA EXPLORATION LIMITED | 28/05/2002 |
Computershare Perth
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Inoviq Ltd | 09/12/2021 |
we understand that on or about this date the company consolidated its shares 1 for 30 | 27/11/2020 |
The suspension of trading in the securities of Bard1 Life Sciences Limited will be lifted immediately, following receipt of a response to an ASX Query. | 18/05/2018 |
The company issues a response to ASX Price Query. | 18/05/2018 |
The company signed an assay development agreement with Thermo Fisher Scientific for Multiplex Research-Use-Only custom assay development. A RUO BARD1 autoantibody assay will be developed using ProcartaPlex Technology for performance on Luminex instrumentation. The first application of the ProcartaPlex Technology is to the BARD1-Ovarian test in development for detection of ovarian cancer. | 18/05/2018 |
The securities of Bard1 Life Sciences Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company, pending the release of an announcement regarding a development contract. | 14/05/2018 |
The securities of BARD1 Life Sciences Limited (previously Eurogold Limited) (the "Company") will be reinstated to official quotation from the commencement of trading on 20 June 2016, following the Company's compliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules. 322,493,350 fully paid ordinary shares | 17/06/2016 |
name changed from Eurogold Limited | 14/06/2016 |
name changed to Inoviq Ltd | 09/12/2021 |
we understand that on or about this date the company consolidated its shares 1 for 30 | 27/11/2020 |
The suspension of trading in the securities of Bard1 Life Sciences Limited will be lifted immediately, following receipt of a response to an ASX Query. | 18/05/2018 |
The company issues a response to ASX Price Query. | 18/05/2018 |
The company signed an assay development agreement with Thermo Fisher Scientific for Multiplex Research-Use-Only custom assay development. A RUO BARD1 autoantibody assay will be developed using ProcartaPlex Technology for performance on Luminex instrumentation. The first application of the ProcartaPlex Technology is to the BARD1-Ovarian test in development for detection of ovarian cancer. | 18/05/2018 |
The securities of Bard1 Life Sciences Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of the Company, pending the release of an announcement regarding a development contract. | 14/05/2018 |
The securities of BARD1 Life Sciences Limited (previously Eurogold Limited) (the "Company") will be reinstated to official quotation from the commencement of trading on 20 June 2016, following the Company's compliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules. 322,493,350 fully paid ordinary shares | 17/06/2016 |
name changed from Eurogold Limited | 14/06/2016 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 21/10/2021 | Philip Powell | 40,000 | $1.085 | $43,400 |
| 04/12/2020 | Geoffrey Cumming | 9,333 | $0.757 | $7,066 |
| 02/12/2020 | Max Johnston | 30,000 | $0.680 | $20,385 |
| 02/12/2020 | Philip Powell | 70,000 | $0.697 | $48,762 |
| 22/11/2019 | Irmgard Irminger-Finger | 347,663 | $0.034 | $11,729 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Geoffrey Cumming | Non Exec Chairman | 28/07/2020 |
| Leearne Hinch | CEO | 07/11/2016 |
| David A. Taylor | Joint Managing Director | 28/09/2001 |
| Allan Cripps | Non Exec Director | 25/01/2020 |
| Max Johnston | Director | 18/06/2019 |
| Philip Powell | Director | 18/06/2019 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Irmgard Irminger-Finger | Director | 10/06/2016 | 15/01/2021 |
| Helen Fisher | Non Exec Director | 28/07/2020 | 25/11/2020 |
| Peter Gunzburg | Executive Chairman, CEO | 24/09/2001 | 28/07/2020 |
| Brett Montgomery | Non Exec Director | 15/08/1989 | 18/06/2019 |
| Geoffrey Laurent | Director | 10/06/2016 | 12/08/2018 |
| Pauline Collinson | Non Exec Director, Company Secretary | 18/11/2014 | 10/06/2016 |
| Arthur Dew | Non Exec Director | 23/10/2012 | 18/11/2014 |
| Lyle Procter | Non Exec Director | 29/11/2012 | 18/11/2014 |
| Mark Wong | Alternate Director | 07/12/2012 | 17/11/2014 |
| Neil MacLachlan | Non Exec Director | 13/07/2004 | 23/10/2012 |
| Dennis Franks | Non Exec Director | 24/09/2001 | 22/12/2006 |
| Christopher Barker | Non Exec Director | 28/07/2006 | |
| Maxwell Montgomery | Alternate Director | 07/11/2001 | |
| David Semmens | Alternate Director | 05/10/2001 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
